Publications by authors named "Lucas Raynaud"

Claim this Profile
C
Chemoembolization using streptozotocin versus embolization in metastatic NETs.
Anne-Laure Védie, Francesco Matteini, Jérôme Cros, Marco Dioguardi Burgio, Jules Grégory, Lucas Raynaud

Endocr Relat Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety and Effectiveness of Hepatic Transarterial Embolic Locoregional Therapy in Patients with Contraindications to Hepatectomy after Portal Vein Embolization.
Raphaël Bacquet, Marco Dioguardi Burgio, Jules Gregory, Mohamed Bouattour, François Cauchy, Lucas Raynaud

J Vasc Interv Radiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia.
Quentin Vanderbecq, Jules Grégory, Jeremy Dana, Marco Dioguardi Burgio, Lorenzo Garzelli, Lucas Raynaud

Diagn Interv Imaging· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment.
Jessica Assouline, Roberto Cannella, Giorgia Porrello, Louis de Mestier, Marco Dioguardi Burgio, Lucas Raynaud

Radiol Imaging Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reperfusion injury on computed tomography following endovascular revascularization of acute mesenteric ischemia: prevalence, risk factors, and patient outcome.
Lorenzo Garzelli, Alexandre Nuzzo, Annick Hamon, Iannis Ben Abdallah, Jules Gregory, Lucas Raynaud

Insights Imaging· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular revascularization of acute arterial mesenteric ischemia: report of a 3-year experience from an intestinal stroke center unit.
MiIan Najdawi, Lorenzo Garzelli, Alexandre Nuzzo, Audrey Huguet, Lucas Raynaud

Eur Radiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
Atanas Pachev, Lucas Raynaud, Luisa Paulatto, Marco Dioguardi Burgio, Vincent Roche

Eur Radiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
Atanas Pachev, Lucas Raynaud, Luisa Paulatto, Marco Dioguardi Burgio, Vincent Roche

Eur Radiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated with Tumor Progression After Percutaneous Ablation of Hepatocellular Carcinoma: Comparison Between Monopolar Radiofrequency and Microwaves. Results of a Propensity Score Matching Analysis.
Damien Bouda, Vincent Barrau, Lucas Raynaud, Marco Dioguardi Burgio, Luisa Paulatto

Cardiovasc Intervent Radiol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extension of COVID-19 pulmonary parenchyma lesions based on real-life visual assessment on initial chest CT is an independent predictor of poor patient outcome.
Jules Grégory, Lucas Raynaud, Adrien Galy, Félix Corre, Jean Charles Bijot

Infect Dis (Lond)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry.
Thierry de Baere, Boris Guiu, Maxime Ronot, Patrick Chevallier, Géraldine Sergent, Lucas Raynaud

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.
Jules Gregory, Anita Paisant, Luisa Paulatto, Lucas Raynaud, Caroline Bertin

Eur J Radiol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
Morgane Van Wettere, Luisa Paulatto, Lucas Raynaud, Onorina Bruno, Audrey Payancé

JHEP Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of liver tumours: What's new?
Valérie Vilgrain, Lucas Raynaud, Luisa Paulatto, Maxime Ronot

Liver Int· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is magnetic resonance imaging useful for the management of patients with rectal villous adenoma? A study of 45 consecutive patients treated by transanal endoscopic microsurgery.
Lucas Raynaud, Diane Mege, Magaly Zappa, Nathalie Guedj, Valérie Vilgrain

Int J Colorectal Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis